Twist Bioscience Corp (TWST)
42.23
+0.57
(+1.37%)
USD |
NASDAQ |
Nov 22, 16:00
42.26
+0.03
(+0.07%)
After-Hours: 20:00
Twist Bioscience Cash from Investing (Quarterly): -1.285M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -1.285M |
June 30, 2024 | -0.711M |
March 31, 2024 | -5.24M |
December 31, 2023 | 4.165M |
September 30, 2023 | -2.247M |
June 30, 2023 | 18.67M |
March 31, 2023 | 41.16M |
December 31, 2022 | -6.971M |
September 30, 2022 | 2.783M |
June 30, 2022 | 4.163M |
March 31, 2022 | -13.29M |
December 31, 2021 | -226.58M |
September 30, 2021 | 23.91M |
June 30, 2021 | 104.58M |
Date | Value |
---|---|
March 31, 2021 | 73.59M |
December 31, 2020 | -45.92M |
September 30, 2020 | -94.67M |
June 30, 2020 | -61.15M |
March 31, 2020 | 28.76M |
December 31, 2019 | 12.40M |
September 30, 2019 | -1.187M |
June 30, 2019 | -22.71M |
March 31, 2019 | -15.16M |
December 31, 2018 | -65.76M |
September 30, 2018 | 0.404M |
June 30, 2018 | 4.58M |
March 31, 2018 | 14.11M |
December 31, 2017 | 8.215M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-226.58M
Minimum
Dec 2021
104.58M
Maximum
Jun 2021
-7.194M
Average
1.036M
Median
Cash from Investing (Quarterly) Benchmarks
Microbot Medical Inc | 0.14M |
Perspective Therapeutics Inc | -29.74M |
Retractable Technologies Inc | 2.926M |
Xtant Medical Holdings Inc | -2.009M |
Catheter Precision Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -15.32M |
Cash from Financing (Quarterly) | 3.627M |
Free Cash Flow | -69.17M |
Free Cash Flow Per Share (Quarterly) | -0.2954 |
Free Cash Flow to Equity (Quarterly) | -17.32M |
Free Cash Flow to Firm (Quarterly) | -17.32M |
Free Cash Flow Yield | -2.82% |